Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

Similar articles for PubMed (Select 23383400)

1.

Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling.

Mizwicki MT, Fiala M, Magpantay L, Aziz N, Sayre J, Liu G, Siani A, Chan D, Martinez-Maza O, Chattopadhyay M, La Cava A.

Am J Neurodegener Dis. 2012;1(3):305-15. Epub 2012 Nov 21.

2.

Tocilizumab infusion therapy normalizes inflammation in sporadic ALS patients.

Fiala M, Mizwicki MT, Weitzman R, Magpantay L, Nishimoto N.

Am J Neurodegener Dis. 2013 Jun 21;2(2):129-39. Print 2013.

3.

IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients.

Fiala M, Chattopadhay M, La Cava A, Tse E, Liu G, Lourenco E, Eskin A, Liu PT, Magpantay L, Tse S, Mahanian M, Weitzman R, Tong J, Nguyen C, Cho T, Koo P, Sayre J, Martinez-Maza O, Rosenthal MJ, Wiedau-Pazos M.

J Neuroinflammation. 2010 Nov 9;7:76. doi: 10.1186/1742-2094-7-76.

4.

Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis.

Hensley K, Fedynyshyn J, Ferrell S, Floyd RA, Gordon B, Grammas P, Hamdheydari L, Mhatre M, Mou S, Pye QN, Stewart C, West M, West S, Williamson KS.

Neurobiol Dis. 2003 Oct;14(1):74-80.

PMID:
13678668
5.
6.

Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients.

Nikolić-Kokić A, Stević Z, Blagojević D, Davidović B, Jones DR, Spasić MB.

Clin Chem Lab Med. 2006;44(5):589-93.

PMID:
16681429
7.

Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models.

Kato S, Kato M, Abe Y, Matsumura T, Nishino T, Aoki M, Itoyama Y, Asayama K, Awaya A, Hirano A, Ohama E.

Acta Neuropathol. 2005 Aug;110(2):101-12. Epub 2005 Jun 28.

PMID:
15983830
8.

Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: inhibition of inflammation by resolvin D1.

Liu G, Fiala M, Mizwicki MT, Sayre J, Magpantay L, Siani A, Mahanian M, Chattopadhyay M, La Cava A, Wiedau-Pazos M.

Am J Neurodegener Dis. 2012;1(1):60-74.

9.

Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils.

Chalaris A, Rabe B, Paliga K, Lange H, Laskay T, Fielding CA, Jones SA, Rose-John S, Scheller J.

Blood. 2007 Sep 15;110(6):1748-55. Epub 2007 Jun 13.

10.

High-Resolution Melting (HRM) Analysis of the Cu/Zn Superoxide Dismutase (SOD1) Gene in Japanese Sporadic Amyotrophic Lateral Sclerosis (SALS) Patients.

Akimoto C, Morita M, Atsuta N, Sobue G, Nakano I.

Neurol Res Int. 2011;2011:165415. doi: 10.1155/2011/165415. Epub 2011 Apr 12.

11.

Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes.

Millecamps S, Boillée S, Le Ber I, Seilhean D, Teyssou E, Giraudeau M, Moigneu C, Vandenberghe N, Danel-Brunaud V, Corcia P, Pradat PF, Le Forestier N, Lacomblez L, Bruneteau G, Camu W, Brice A, Cazeneuve C, Leguern E, Meininger V, Salachas F.

J Med Genet. 2012 Apr;49(4):258-63. doi: 10.1136/jmedgenet-2011-100699.

PMID:
22499346
12.

Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS.

Turner MR, Osei-Lah AD, Hammers A, Al-Chalabi A, Shaw CE, Andersen PM, Brooks DJ, Leigh PN, Mills KR.

J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1279-85.

13.

Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: should all sporadic ALS cases also be screened for SOD1?

Gamez J, Corbera-Bellalta M, Nogales G, Raguer N, García-Arumí E, Badia-Canto M, Lladó-Carbó E, Alvarez-Sabín J.

J Neurol Sci. 2006 Aug 15;247(1):21-8. Epub 2006 May 3.

PMID:
16674979
14.

Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.

Turner MR, Hammers A, Al-Chalabi A, Shaw CE, Andersen PM, Brooks DJ, Leigh PN.

Brain. 2005 Jun;128(Pt 6):1323-9. Epub 2005 Apr 20.

15.

Free insulin-like growth factor (IGF)-1 and IGF-binding proteins-2 and -3 in serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients.

Corbo M, Lunetta C, Magni P, Dozio E, Ruscica M, Adobbati L, Silani V.

Eur J Neurol. 2010 Mar;17(3):398-404. doi: 10.1111/j.1468-1331.2009.02815.x. Epub 2009 Oct 21.

PMID:
19845745
17.

Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS).

Zhang R, Hadlock KG, Do H, Yu S, Honrada R, Champion S, Forshew D, Madison C, Katz J, Miller RG, McGrath MS.

J Neuroimmunol. 2011 Jan;230(1-2):114-23. doi: 10.1016/j.jneuroim.2010.08.012. Epub 2010 Sep 29.

18.

Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

Frutiger K, Lukas TJ, Gorrie G, Ajroud-Driss S, Siddique T.

Amyotroph Lateral Scler. 2008 Jun;9(3):184-7. doi: 10.1080/17482960801984358.

PMID:
18574763
19.

Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2.

Liu Y, Hao W, Dawson A, Liu S, Fassbender K.

J Biol Chem. 2009 Feb 6;284(6):3691-9. doi: 10.1074/jbc.M804446200. Epub 2008 Dec 17.

20.

Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.

Hensley K, Floyd RA, Gordon B, Mou S, Pye QN, Stewart C, West M, Williamson K.

J Neurochem. 2002 Jul;82(2):365-74. Erratum in: J Neurochem 2002 Sep;82(6):1570.

PMID:
12124437
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk